“…Therefore, designing and constructing biomaterial scaffolds to mimic the structure of the EV-ECM complex and the physiological interactions between the ECM and EVs, represents an attractive and promising novel approach for tissue engineering applications. Mesenchymal stem cells (MSCs) isolated from various tissues are multipotent stem cells (Fridenshtein et al, 1968 ; Jo et al, 2007 ; Oh et al, 2008 ; Zannettino et al, 2008 ; Xue et al, 2018 ), represent a promising regenerative treatment for a variety of diseases (Bouffi et al, 2010 ; Lankford et al, 2015 , 2017 ; Wang et al, 2015 ; Brown et al, 2016 ; Hofer and Tuan, 2016 ; Kabagambe et al, 2017 ; Galganski et al, 2019 ; Vanover et al, 2019 ; Zhang Z. et al, 2019 ), especially vascular diseases (Pankajakshan and Agrawal, 2014 ; Premer et al, 2019 ), due to the biofunctional paracrine secretion, including EVs. However, in many of the cases where therapeutic effects were observed using MSCs, the transplanted stem cells did not persist following injection and thus did not contribute to tissue regeneration by integration.…”